Chandra Mani Adhikari

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · The Lancet Oncology · 2019 · 498 citations

Oncology, Medicine, Melanoma +6

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome

Rebecca Simpson, Erin R. Shanahan, Marcel Batten et al. · Nature Medicine · 2022 · 216 citations

Dysbiosis, Host-microbe Interactions, Immunology +13

Spironolactone Reduced Arrhythmia and Maintained Magnesium Homeostasis in Patients With Congestive Heart Failure

Xiuren Gao, Longyun Peng, Chandra Mani Adhikari et al. · Journal of Cardiac Failure · 2007 · 94 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +10

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma

Robert V. Rawson, Chandra Mani Adhikari, Carolien Bierman et al. · Annals of Oncology · 2021 · 56 citations · Full text

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome

Xiu-ren Gao, Chandra Mani Adhikari, Long-yun Peng et al. · Journal of Pharmacy and Pharmacology · 2009 · 44 citations